NPPB and hydrops fetalis: In the DEFINE-HF trial, in which patients with HFrEF received dapagliflozin for 12 weeks, treatment did not affect mean NT-proBNP levels but increased the proportion of patients who experienced a clinically meaningful improvement in their cardiovascular health status or natriuretic peptide levels [15].